Event Details

Acorda Therapeutics, Inc. Provides Update on Tozadenant Development Program

November 15, 2017 Time: 08:30 AM EST

Stock Quote

ACOR (Common Stock) $ 17.86 -1.11 (-5.85%) Volume: 669,509 MORE October 19, 2018

Email Alerts

Un-subscribe from email alerts
Email Address *
Mailing Lists *





 
Enter the code shown above.